CRISPR Therapeutics
Biotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.
About
Technology stack
detected 2026-06-16No comments yet. Be the first to share your take.
What does CRISPR Therapeutics do?
CRISPR Therapeutics is a Swiss-American biotechnology company focused on translating CRISPR/Cas9 gene-editing technology into transformative medicines for serious diseases. They develop cures for genetic diseases by precisely modifying DNA, with a diverse portfolio including treatments for hemoglobinopathies, oncology, and regenerative medicine. Their lead program, exagamglogene autotemcel (exa-cel), has received regulatory approval in several countries for sickle cell disease and transfusion-de…
How much funding has CRISPR Therapeutics raised?
CRISPR Therapeutics has raised a total of $547M in funding. The most recent round on record is Series B.
Where is CRISPR Therapeutics headquartered?
CRISPR Therapeutics is headquartered in Zug, Switzerland.
When was CRISPR Therapeutics founded?
CRISPR Therapeutics was founded in 2013.
What industry does CRISPR Therapeutics operate in?
CRISPR Therapeutics operates in Biotechnology, Gene Editing, Therapeutics, Pharmaceuticals.